Electromed, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Electromed, Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 15.1 times. Higher than 96% of Healthcare companies in United States.
- Cash Locked Ratio: For every $100 of sales, $45 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $56 tied up three years earlier. More money tied up than 88% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
$126Over the last 3 years, every $100 of reported profit came with $126 of operating cash.
Lower than 67% of Healthcare companies in United States.
Self-Funding Ratio
15.1×Over the last 3 years its own operating cash covered its investment spending (capex) 15.1 times.
Higher than 96% of Healthcare companies in United States.
Cash Locked Ratio
$45For every $100 of sales, $45 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $56 tied up three years earlier.
More money tied up than 88% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
$32Sales grew 53% in 3 years; of every extra $100 of sales, $32 became extra profit.
Higher than 59% of Healthcare companies in United States.
Asset Productivity Ratio
+53% / +45%In 3 years sales changed by +53% while total assets changed by +45%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
98%Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 83% of Healthcare companies in United States.
Tangible Net Worth Ratio
97%Of every $100 of net worth, $97 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 86% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Electromed, Inc. owes $0.19 for every $1 it owns. Net profit rose 50% in the year to Jun 2026, and grew 53% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Jun 2026.
P/E ratio
20.7Investors pay $20.7 for every $1 of Electromed, Inc.'s yearly profit, lower than 63% of Healthcare companies in United States.
P/B ratio
4.13The share price is 4.13 times Electromed, Inc.'s book value per share, higher than 66% of Healthcare companies in United States.
Market cap
$223 MThe total market value of all of Electromed, Inc.'s shares at today's price (share price × number of shares), smaller than 57% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$54 MWhat Electromed, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$6.51Net worth divided by the number of shares. The share price of $26.87 is 4.1 times this, which is the P/B above.
Return on equity (ROE)
23.3%Electromed, Inc. earned 23.3% on its shareholders' money over the last year, higher than 92% of Healthcare companies in United States.
Owes vs Owns
0.19×Electromed, Inc. owes $0.19 for every $1 it owns (low), lower than 75% of Healthcare companies in United States.
Dividend yield
NoneElectromed, Inc. does not currently pay a dividend.
Revenue growth
+15%Revenue rose 15% in the year to Jun 2026, and grew 15% a year on average over 3 years.
Profit growth
+50%Net profit rose 50% in the year to Jun 2026, and grew 53% a year on average over 3 years.
Profit margin
15.3%Electromed, Inc. keeps $15 of every $100 of revenue as net profit.
Cash quality
0.9×Cash from Electromed, Inc.'s business was 0.9× its reported profit in the year to Jun 2026 — less cash came in than the profit reported.
Questions
What is Electromed, Inc.'s P/E ratio?
Investors pay $20.7 for every $1 of Electromed, Inc.'s yearly profit, lower than 63% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Electromed, Inc.: $223 M ÷ $54 M (30 Jun 2026) = 4.1.
What is Electromed, Inc.'s return on equity?
Electromed, Inc. earned 23.3% on its shareholders' money over the last year, higher than 92% of Healthcare companies in United States.
How much does Electromed, Inc. owe compared with what it owns?
Electromed, Inc. owes $0.19 for every $1 it owns (low), lower than 75% of Healthcare companies in United States.
Does Electromed, Inc. pay a dividend?
No. Electromed, Inc. does not currently pay a dividend.
Is Electromed, Inc.'s revenue growing?
Revenue rose 15% in the year to Jun 2026, and grew 15% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.